Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States

被引：0
|
作者：
Feldman, Steven R. [1 ]
Guerin, Annie [2 ]
Gauthier-Loiselle, Marjolaine [2 ]
Claxton, Ami J. [3 ]
Hazra, Nisha C. [4 ]
Meng, Yan [4 ]
Gallant, Kirsten [4 ]
Balu, Sanjeev [3 ]
机构：
[1] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] LEO Pharma, Madison, NJ USA
[4] Anal Grp Inc, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷
关键词：
atopic dermatitis; work productivity and activity impairment; disease burden; comorbidity;
D O I：
10.1093/bjd/ljad498.047
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
547
引用
收藏
页码：II45 / II46
页数：2
相关论文
共 50 条
  • [21] Risk of major adverse cardiovascular events in patients with moderate-to-severe atopic dermatitis: a United States population-based study
    Bunick, Christopher G.
    Grada, Ayman
    Del Rosso, James
    Armstrong, April W.
    Yue, Emma
    Krueger, Whitney
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [22] Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitis
    van Der Rijst, Lisa P.
    Veldhuis, Nienke
    van Der Kamp, Sara
    Achten, Roselie E.
    van Luijk, Chantal M.
    Voskuil-Kerkhof, Elsbeth S. M.
    Haeck, Inge M.
    de Bruin-Weller, Marjolein S.
    de Graaf, Marlies
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2025, 36 (02)
  • [23] Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
    Dupuis, Josephine
    Tauber, Marie
    Mahe, Emmanuel
    Jachiet, Marie
    Soria, Angele
    Tetart, Florence
    Puzenat, Eve
    Pasteur, Justine
    Raison-Peyron, Nadia
    Giordano-Labadie, Francoise
    Droitcourt, Catherine
    Leleu, Camille
    Nosbaum, Audrey
    Aubert, Helene
    Moigne, Marie L. E.
    Bernier, Claire
    Barbarot, Sebastien
    Ezzedine, Khaled
    Diaz, Emmanuelle
    Hubiche, Thomas
    Faiz, Sarah
    Azib, Selma
    Dezoteux, Frederic
    Chosidow, Olivier
    Staumont-Salle, Delphine
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e174 - e178
  • [24] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Eichenfield, L. F.
    Blauvelt, A.
    Rosmarin, D.
    Hussain, I.
    Davis, J. D.
    Li, M.
    Zhang, Q.
    Gadkari, A.
    Eckert, L.
    Kamal, M. A.
    Bansal, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
  • [25] Ocular surface disease is common in moderate-to-severe atopic dermatitis patients
    Achten, Roselie E.
    Bakker, Daphne S.
    van Luijk, Chantal M.
    van Der Wal, Marlot
    de Graaf, Marlies
    van Wijk, Femke
    Zuithoff, Nicolaas P. A.
    van Der Rijst, Lisa P.
    Boesjes, Celeste M.
    Thijs, Judith L.
    de Boer, Joke H.
    de Bruin-Weller, Marjolein S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (06): : 801 - 805
  • [26] Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice
    Schloesser, Anne R.
    Shareef, Madena
    Olydam, Jill
    Nijsten, Tamar E. C.
    Hijnen, Dirk Jan
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (05) : 510 - 517
  • [27] Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Facheris, Paola
    Gomez-Arias, Pedro Jesus
    Del Duca, Ester
    Da Rosa, Joel Correa
    Weidinger, Stephan
    Bissonnette, Robert
    Armstrong, April W.
    Seneschal, Julien
    Eyerich, Kilian
    Estrada, Yeriel D.
    Bose, Swaroop N.
    Xu, Dan
    Chen, Allshine
    Tatulych, Svitlana
    Guler, Erman
    Chan, Gary
    Page, Karen M.
    Kerkmann, Urs
    ALLERGY, 2024, 79 (05) : 1258 - 1270
  • [28] Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van der Schaft, J.
    Bakker, D.
    Ariens, L.
    Thijs, J. H.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 82 - 82
  • [29] Improvements in work productivity following baricitinib treatment in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5
    Eichenfield, Lawrence F.
    Maverakis, Emanual
    Tan, Jerry
    Albrecht, Lorne
    Buchanan, Andrew
    DeLozier, Amy M.
    Zhong, Jinglin
    Sun, Luna
    Rosmarin, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB58 - AB58
  • [30] Safety of amlitelimab in a Phase 2a clinical trial of patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Cork, Michael
    Reich, Adam
    Bieber, Thomas
    Gilbert, Sally
    Quaratino, Sonia
    Wilson, Rosamund
    Porter-Brown, Ben
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
12345